David A. Rosa - 14 Feb 2025 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
Director
Signature
/s/ David Rosa
Issuer symbol
BRTX
Transactions as of
14 Feb 2025
Net transactions value
$0
Form type
4
Filing time
19 Feb 2025, 16:33:37 UTC
Previous filing
04 Feb 2025
Next filing
20 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRTX Stock Option Award $0 +52,632 $0.000000 52,632 14 Feb 2025 Common Stock 52,632 $2.46 Direct F2
holding BRTX Stock Option 10,490 14 Feb 2025 Common Stock 10,490 $5.08 Direct F1
holding BRTX Stock Option 32,028 14 Feb 2025 Common Stock 32,028 $2.91 Direct F1
holding BRTX Stock Option 79,646 14 Feb 2025 Common Stock 79,646 $1.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is currently exercisable.
F2 The option vests and becomes exercisable in twelve nearly equal monthly installments of 4,386 shares beginning on March 14, 2025 and continuing every month thereafter until fully vested.